Trading--Leveraged Equity · NASDAQ · USD · Data as of 2026-05-14
AUM
$17.58M
Expense ratio
1.07%
Yield
16.07%
YTD return
-30.77%
Last price
$22.86
Leveraged · Coverage 50% · low
Today
40.8
Outlook
45.3
Block A (composite-derived)
44.2
Block C (market behavior)
36.1
Today overlay (Block D)
0.0
Outlook overlay (Block D)
0.0
today_score = clip(0,100, 50 + 0.15·(A−50) + 0.60·(C−50) + D_today). Block B (holdings rollup) is in Phase 3 development; β=0 caps the natural range at ~12.5–87.5 in Preview v0.9. Formula version tide-etf-v1.0.0.
44.2
Coverage 50% · low
Liquidity
—
Expenses
25.0
Performance
—
Volatility
28.6
Dividend
55.6
Concentration
85.0
Smart Money
—
Activist
—
Formula version composite-v1.0.0. Axes hover to see why a sub-score is missing.
Editorial coverage for ELIL is coming soon — copy is rolling out to the broader universe ETF-by-ETF in 2026Q2.
Direxion Daily LLY Bull 2X Shares is a type of leveraged exchange-traded fund (ETF) designed to provide twice the daily performance of the underlying asset it tracks, which is the stock of Eli Lilly and Company. This leveraged ETF allows investors to gain amplified exposure to the pharmaceutical sector, capitalizing on the bullish movements of Eli Lilly's stock with a twofold impact on their investment. These types of funds are primarily used by traders who have a short-term investment horizon and aim to exploit daily price fluctuations. Direxion Daily LLY Bull 2X Shares garners significant attention in the financial market due to its ability to magnify potential short-term gains, while also bearing the risk of amplified losses. Such leveraged products require careful consideration of the inherent risks and are intended for experienced investors who are comfortable managing higher volatility and complexity in their investment portfolios.
Net AUM change history is not yet available for this ETF. Fund-flow time series is a Phase B deliverable.
Current AUM: $17,584,796. AUM change is computed from rolling daily fundamentals snapshots; it reflects total net-asset deltas (creations/redemptions + market value moves), not pure share creations.
Fund documents (fact sheets, prospectuses, semi-annual reports) for ELIL are coming soon. The BW fund-document archive will surface PDFs alongside a metadata index for searchability.